Mednet Logo
HomeRheumatology
Rheumatology

Rheumatology

Clinical discussions on autoimmune diseases, biologic therapies, vasculitis, and musculoskeletal conditions.

Recent Discussions

What is your approach to progressive calvarial hyperostosis found in an elderly adult not caused by Pagets, acromegaly or hypercalcemia?

1
1 Answers

Mednet Member
Mednet Member
Endocrinology · Milwaukee Va Medical Center

Does your patient have meningioma? Is the osteosclerosis generalized or localized? Localized osteosclerosis can arise from tumors (either benign or malignant) that secrete osteogenic proteins. I have had such a patient, with the unresectable meningioma secreting endothelin. Endothelin is also secret...

What is your management approach for patients with Adult Onset Still's who are planning pregnancy?

1 Answers

Mednet Member
Mednet Member
Rheumatology · UT Southwestern Medical Center

Adult Onset Still's Disease is an uncommon disorder. There are a paucity of studies of this disease during pregnancy. Nonetheless, as rheumatologists, we are occasionally asked to manage these patients during pregnancy. The treatment of Adult Onset Still's Disease includes NSAIDs, glucocorticoids, m...

At what point in GCA management do you typically introduce tocilizumab?

1
2 Answers

Mednet Member
Mednet Member
Rheumatology · Massachusetts General Hospital

I typically introduce tocilizumab as first line therapy in combination with prednisone in patients who do not have a contraindication. The GIACTA trial demonstrated the superiority of TCZ+prednisone x 6 mos over prednisone alone x 6 or 12 months with numerically fewer serious adverse events. Given t...

When do you consider the use of JAK inhibitors for cutaneous manifestations of myositis?

1 Answers

Mednet Member
Mednet Member
Rheumatology · The University of Texas Health Science Center at Houston (UTHealth)

JAK inhibitors have been shown to be effective especially for skin manifestations in dermatomyositis in an open-label trial (Paik et al., PMID 33258553). However, given the limitations imposed by insurance companies, I consider JAK inhibitors most commonly in the following scenarios: when the patien...

Would you escalate therapy in a patient with rheumatoid arthritis without synovitis, but a new rheumatoid nodule?

2
1 Answers

Mednet Member
Mednet Member
Rheumatology · Harvard Medical School

The appearance of a new nodule in someone without synovitis is puzzling. If it is truly a rheumatoid nodule, their RF should be positive. These patients have a heightened risk for the development of full blown RA in the future. However, the appearance of a nodule without synovitis being present does...

How do you approach the treatment of bullous cutaneous lupus?

1
1 Answers

Mednet Member
Mednet Member
Rheumatology · Uniformed Services University of the Health Sciences (USUHS)

First, I ensure that the diagnosis is correct (referring to my favorite local medical dermatologist) and that it is not a non-lupus-related bullous disease. As most would do, I use hydroxychloroquine plus dapsone as my initial treatment of choice along with strict ultraviolet light protection measur...

Would you modify your treatment approach for treating an HPV-positive head and neck cancer in a patient with symptomatic Sjogren's?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · HCA South Atlantic

Patients with Sjögren’s syndrome have baseline xerostomia of variable severity. Management of Head and Neck cancer in this population depends on the location and stage of the primary. I would prefer to treat them with primary surgery if at all possible. If RT is necessary either as primary modality ...

When would you consider utilizing bone scintigraphy in the assessment of inflammatory arthritis?

2 Answers

Mednet Member
Mednet Member
Rheumatology · Hospital Perea

When it's a case of negative RA disease or when considering a neoplastic, gammopathy with myeloma...

Do you typically adjust or hold immunosuppression in a well-controlled RA patient who is being treated for Mycobacterium avium-intracellulare (MAI)?

1
1 Answers

Mednet Member
Mednet Member
Infectious Disease · Mayo Clinic Health System

It depends on the RA activity and shared decision-making with the patient. A lot of these patients are at risk of MAI infection due to their underlying immunosuppression and on higher levels of immunosuppression because they have more severe rheumatoid disease process. Very often it is difficult for...

How would you approach a pulmonary-renal PR3+ ANCA vasculitis patient who has persistent re-narrowing of mainstem bronchus after several dilatation and stenting procedures, with other anca features well-controlled on rituximab & avacopan?

2
5 Answers

Mednet Member
Mednet Member
Rheumatology · Harvard Medical School

Obviously, this is going to be a very challenging management issue. Bronchial or tracheobronchial stenosis evolves independently of other organ involvement and often fails to respond to immune suppressive regimens. There is one anecdotal study from France, suggesting that cyclophosphamide may offer ...